Condition

Neoplasm, Breast

ClinicalTrials.gov condition label

Clinical trials14
Recruiting5
Common interventions25
Lead sponsors shown14

Clinical trials

14 shown
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNCT06251544 · 2026-08-03
RECRUITING
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)NCT05465031 · 2024-04-17
RECRUITING
TCM Therapy Program Impact on Breast Cancer Patients' Vital EnergyNCT06337214 · 2024-03-13
RECRUITING
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal StudyNCT05851053 · 2022-09-01
RECRUITING
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26
RECRUITING
Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening ProgramsNCT05512260 · 2023-03-01
WITHDRAWN
Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.NCT05507034 · 2022-10-04
UNKNOWN
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)NCT05392608 · 2022-06-02
ACTIVE_NOT_RECRUITING
Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast CancerNCT05033769 · 2021-03-11
UNKNOWN
Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer PatientsNCT04678544 · 2020-12-23
COMPLETED
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast CancerNCT03756064 · 2019-08-01
UNKNOWN
9-ING-41 in Patients With Advanced CancersNCT03678883 · 2019-01-04
ACTIVE_NOT_RECRUITING
To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph NodesNCT03715686 · 2018-10-20
UNKNOWN
DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) ProteinNCT03368196 · 2018-04-02
COMPLETED

Common interventions

9-ING-41DRUG1Alpelisib 150 MG Oral Tablet [Piqray]DRUG1Axillary lymph node dissectionPROCEDURE1Axillary radiotherapyRADIATION1BiomarkersDIAGNOSTIC_TEST1Breast or chest wall radiotherapyRADIATION1CarboplatinDRUG1Carboplatin.DRUG1DocetaxelDRUG1Doxorubicin.DRUG1DS-8201aDRUG1EchocardiographyDIAGNOSTIC_TEST1Eribulin Injection [Halaven]DRUG1FulvestrantDRUG1Gemcitabine - 21 day cycleDRUG1Gemcitabine - 28 day cycleDRUG1HTR2 T CellsGENETIC1Individual decision aid (iDA)DEVICE1IrinotecanDRUG1LomustineDRUG1Nab paclitaxel.DRUG1Paclitaxel injectionDRUG1Paclitaxel.DRUG1PlaceboDRUG1Placebo Oral TabletDRUG1

Trial status mix

RECRUITING5
UNKNOWN4
ACTIVE_NOT_RECRUITING2
COMPLETED2
WITHDRAWN1

Phase mix

NA6
PHASE12
PHASE22
PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.